Scientists discover migrions that accelerate viral infections

Researchers have identified migrions, virus-like structures that enable faster and more severe viral spread by hijacking cell movement. These packages, formed in migrating cells infected with vesicular stomatitis virus, deliver multiple viral genomes simultaneously to new cells. The discovery challenges traditional models of infection and highlights increased disease potential in animal tests.

A team from Peking University Health Science Center and the Harbin Veterinary Research Institute has revealed a novel mechanism of viral transmission detailed in a study published in Science Bulletin. The research focuses on vesicular stomatitis virus (VSV), where infected cells pack viral genetic material and proteins into migrasomes—cellular structures that emerge during cell migration.

These migrasomes, containing viral nucleic acids and displaying the VSV surface protein VSV-G, form large virus-like entities dubbed "migrions." Unlike individual virus particles, migrions combine viral and cellular components, allowing for collective delivery. This bundling enables quicker replication in recipient cells, as multiple viral genomes arrive at once, initiating parallel infection processes.

Migrions stand out for their ability to transport more than one virus type simultaneously, differing from standard extracellular vesicle transmission. Upon reaching a new cell, they enter via endocytosis. Acidic conditions inside then activate VSV-G, prompting fusion with endosomes and release of viral contents to kickstart replication.

In mouse experiments, migrion-mediated infections proved far more potent than free virus exposure. Affected animals suffered severe lung and brain conditions, including encephalitis, often leading to fatal outcomes. This underscores the heightened pathogenicity of the migration-linked route.

The researchers describe migrions as a chimeric structure bridging viruses and migrasomes, introducing a migration-dependent transmission model. By exploiting the body's migratory systems, viruses can propagate more efficiently and systemically, potentially explaining rapid escalations in certain infections.

Mga Kaugnay na Artikulo

Photorealistic lab scene depicting DoriVac DNA origami vaccine triggering strong immune responses in mouse and organ chip models, as an advance over mRNA vaccines.
Larawang ginawa ng AI

DNA origami “DoriVac” shows strong immune activation in early tests, offering a potential complement to mRNA vaccines

Iniulat ng AI Larawang ginawa ng AI Fact checked

Researchers at Harvard’s Wyss Institute and Dana-Farber Cancer Institute report that a DNA origami-based vaccine platform called DoriVac generated robust immune responses in mice and in a human lymph node “Organ Chip” model. The team says the approach could be easier to store and manufacture than lipid nanoparticle–delivered mRNA vaccines, though the work remains preclinical. The results were published in Nature Biomedical Engineering.

Scientists at Arizona State University have identified two unexpected ways bacteria can spread without their usual flagella structures. In one study, E. coli and salmonella use sugar fermentation to create fluid currents for surface migration, dubbed 'swashing.' A separate study reveals a molecular 'gearbox' in flavobacteria that controls directional movement.

Iniulat ng AI

Researchers found that infecting mice with respiratory syncytial virus (RSV) reduced breast cancer cells' ability to form tumors in the lungs by 65 to 70 percent. The effect stems from type I interferons, proteins that fight viral replication and hinder cancer cell seeding. The study raises hopes for drugs mimicking this mechanism.

Researchers from the University of Geneva and Lausanne University Hospital report they have visualized, in three dimensions and under near-native conditions, how cytotoxic T cells organize their killing machinery at the immune synapse. The work, published in Cell Reports, applies cryo-expansion microscopy to human T cells and to tumor tissue samples, providing nanoscale views intended to support immunology and cancer research.

Iniulat ng AI

Researchers at Fred Hutch Cancer Center have created human-like monoclonal antibodies that prevent Epstein-Barr virus (EBV) from infecting immune cells. Using mice engineered with human antibody genes, the team identified antibodies targeting viral proteins gp350 and gp42, with one fully blocking infection in lab models. The findings, published in Cell Reports Medicine, could lead to therapies for transplant patients at risk of EBV-related complications.

Gumagamit ng cookies ang website na ito

Gumagamit kami ng cookies para sa analytics upang mapabuti ang aming site. Basahin ang aming patakaran sa privacy para sa higit pang impormasyon.
Tanggihan